Jim Simons’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$51M Buy
3,299,200
+141,500
+4% +$2.19M 0.07% 335
2025
Q1
$47M Buy
3,157,700
+78,300
+3% +$1.16M 0.07% 344
2024
Q4
$40.8M Sell
3,079,400
-139,400
-4% -$1.85M 0.06% 388
2024
Q3
$45.8M Buy
3,218,800
+264,000
+9% +$3.75M 0.07% 344
2024
Q2
$38.2M Sell
2,954,800
-163,400
-5% -$2.11M 0.06% 367
2024
Q1
$43.3M Sell
3,118,200
-209,200
-6% -$2.91M 0.07% 346
2023
Q4
$47.5M Buy
3,327,400
+96,500
+3% +$1.38M 0.07% 313
2023
Q3
$50M Sell
3,230,900
-419,100
-11% -$6.48M 0.09% 270
2023
Q2
$57.3M Buy
3,650,000
+676,600
+23% +$10.6M 0.08% 279
2023
Q1
$49M Buy
2,973,400
+109,000
+4% +$1.8M 0.07% 355
2022
Q4
$44.7M Buy
2,864,400
+15,300
+0.5% +$239K 0.06% 373
2022
Q3
$37M Buy
2,849,100
+20,800
+0.7% +$270K 0.05% 417
2022
Q2
$39.7M Buy
2,828,300
+835,100
+42% +$11.7M 0.05% 433
2022
Q1
$28.5M Buy
1,993,200
+274,400
+16% +$3.93M 0.03% 563
2021
Q4
$23.4M Sell
1,718,800
-438,100
-20% -$5.97M 0.03% 633
2021
Q3
$35.3M Sell
2,156,900
-140,100
-6% -$2.29M 0.05% 415
2021
Q2
$38.7M Sell
2,297,000
-1,137,600
-33% -$19.1M 0.05% 419
2021
Q1
$62.7M Sell
3,434,600
-2,144,100
-38% -$39.2M 0.08% 278
2020
Q4
$102M Sell
5,578,700
-158,007
-3% -$2.88M 0.11% 185
2020
Q3
$102M Buy
5,736,707
+129,007
+2% +$2.3M 0.1% 201
2020
Q2
$101M Buy
5,607,700
+1,844,300
+49% +$33.1M 0.09% 244
2020
Q1
$57.1M Buy
3,763,400
+1,755,211
+87% +$26.6M 0.06% 351
2019
Q4
$39.6M Buy
2,008,189
+303,789
+18% +$5.99M 0.03% 637
2019
Q3
$29.3M Buy
1,704,400
+930,600
+120% +$16M 0.02% 749
2019
Q2
$13.7M Buy
+773,800
New +$13.7M 0.01% 1198